📜 iter-4360dd15-0106.log
21397 bytes
# Iter-0106 mission=4360dd15
# goal: 找到让人类长生不老的方法
# time: 2026-04-26T03:16:11
# focus_node: root :: 找到让人类长生不老的方法
========== TRANSCRIPT ==========
→ call task_view({"max_depth":6})
【tool:task_view】
{"ok": true, "tree": "GOAL: 找到让人类长生不老的方法\n· [✓ done ] root: 找到让人类长生不老的方法\n├─ [✓ done ] n1: 建立 marker 锚定后的局部交换判定框架 ← 已完成 marker 锚定后的局部交换判定框架：固定 μ 锚点、排除触及 μ 的交换、用 greedy witness span 压缩候选窗口，并在触及 wit\n│ ├─ [✓ done ] n5: 规范化 witness：固定 μ 锚点并限制一次交换的位置 ← 完成 witness 规范化：确认固定 μ 锚点时必须排除触碰 μ 的交换，并用 greedy witness span 将允许交换压缩到局部窗口内；小规模穷举\n│ │ ├─ [✓ done ] n9: 证伪一次交换跨越 μ 的规范化可能性 ← 用穷举验证并归纳出结构性事实：任何触及唯一 marker μ 的相邻交换都会使 μ 的位置改变 1，因此在固定 μ 位置的 witness 规范化里，不存在“跨\n│ │ ├─ [✓ done ] n10: 把单侧交换位置压缩为可判定窗口 ← 证明并穷举验证：对左块 greedy witness 的最左/最右嵌入位置 p1..pk，窗口外相邻交换不会改变最大前缀消耗 k，因此允许交换位置可压缩为 [p\n│ │ └─ [✓ done ] n11: 沉淀 witness 规范形模板 ← 沉淀出 witness 规范形模板：固定 μ 锚点、排除触及 μ 的交换、以 greedy witness span 限定局部窗口，并用左块最大前缀消耗 k 作\n│ ├─ [✓ done ] n6: 建立单侧切分判定接口：把可行性压成存在切分点 k ← 把固定 μ 锚点后的可行性压成了单侧切分接口：左块只通过最大前缀消耗长度 k 传递，且 k 由 X 决定、与 Y 无关。\n│ ├─ [✓ done ] n7: 刻画交换不依赖右侧的充分条件 ← 验证了一个可复用充分条件：若一次相邻交换不改变对任意 S 的左块最大前缀消耗 k，则对所有右侧 Y 的可行性判定保持不变；并用穷举检查了 small-case \n│ ├─ [✓ done ] n8: 沉淀可复用的验证模板与失败边界 ← 找到验证模板的失败边界：任意 witness span 不够，必须用 greedy witness span；给出反例 X=abb, S=ba，窗口外交换仍可改\n│ ├─ [✓ done ] n12: 探索两次相邻交换下 greedy witness span 的局部性边界 ← 在二元字母表、长度 n<=8 的穷举中，未找到“两个相邻交换都发生在原始 greedy witness span 之外却改变 k”的反例；这给出了多交换局部性边\n│ ├─ [✓ done ] n13: 把 marker 锚定后的局部交换判定落实为可执行的 O(n)~O(n log n) 检查流程 ← 完成了一个可执行的局部交换检查流程：先算 k，再用 greedy witness span 的局部闭包限制候选交换；对二元字母表、|X|<=8、|S|<=8 的\n│ ├─ [✓ done ] n14: 证伪 greedy witne
→ call search_memory({"limit":5,"mission_only":false,"query":"39630941 Figure 2 Figure 6 纵向 采样日 定量 读出 ABT-263"})
【tool:search_memory】
{"ok": true, "results": [{"title": "序贯干预中的 schedule anchor 与 recovery anchor 必须分离", "tags": "fact method lesson ABT-263 [[wound healing]]", "mission": "", "modified": "20260425190835000", "preview": "!! 纵向时间序列是区分“炎症/修复被触发”与“回落完成”的唯一可靠方式 [[Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing]] 这类局部 senolytic 研究如果只提供给药结束点、造伤点和“temporary inflammatory response / macrophage infiltration”这样的定性结论，就不能把任何单点解释为“恢复已完成”。必须把 ''schedule anchor''（给药结束、造伤时点）与 ''recovery anchor''（炎症、免疫浸润、修复转录、组织学回落到基线的时间点）分开。 !! 从 PMID 39630941 / PMC11810067 可直接核出的时间信息 # 局部 ABT-263（5 μM"}, {"title": "全文被拦截时的 PubMed XML 回退", "tags": "method principle [[[[ABT-263 后炎症与修复回落必须靠纵向时间序列判定]]]] [[[[topical ABT-263 的皮肤生物学恢复缓冲期]]]] [[序贯干预必须显式检索“先后顺序”]] lesson", "mission": "4360dd15", "modified": "20260425191419000", "preview": "当全文网页被 reCAPTCHA 或类似机制挡住时，先用 PubMed 锁定 PMID，再用 eutils 的 efetch XML 取结构化内容，通常比继续硬抓 HTML 更稳。对于需要抽取图注、时间点和读出的任务，这种回退路径能把关键线索从不可访问页面里救出来，正好支撑 [[ABT-263 后炎症与修复回落必须靠纵向时间序列判定]] 这类判断。"}, {"title": "ABT-263 后炎症与修复回落必须靠纵向时间序列判定", "tags": "fact lesson method ABT-263 OSK [[Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing]]", "mission": "", "modified": "20260425190313000", "preview": "!! ABT-263 后炎症与修复回落的时间序列只能从纵向读出判定 当局部 senolytic 研究只给出给药结束、造伤时点和“temporary inflammatory response / macrophage infiltration”这类定性结论时，不能把其中任意一个单点当作“恢复已完成”的证据。[[Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound heali
→ call web_fetch({"max_chars":12000,"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11810067/"})
【tool:web_fetch】
{"ok": true, "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11810067/", "status": 200, "content_type": "text/html; charset=utf-8", "text": "Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.", "truncated": false}
→ call web_search({"limit":5,"query":"PMC11810067 XML Figure 2 Figure 6 Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing"})
【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}
→ call web_fetch({"max_chars":20000,"url":"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39630941&retmode=xml"})
【tool:web_fetch】
{"ok": true, "url": "https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39630941&retmode=xml", "status": 200, "content_type": "text/xml; charset=UTF-8", "text": "39630941 2025 04 26 2026 04 08 1945-4589 17 1 2024 Dec 03 Aging Aging (Albany NY) Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing. 16 32 16-32 10.18632/aging.206165 Senescent cells accumulate in aging tissues, impairing their ability to undergo repair and regeneration following injury. Previous research has demonstrated that targeting tissue senescence with senolytics can enhance tissue regeneration and repair by selectively eliminating SnCs in specific aged tissues. In this study, we focused on eliminating senescent skin cells in aged mice to assess the effects on subsequent wound healing. We applied ABT-263 directly to the skin of 24-month-old mice over a 5-day period. Following topical ABT-263, aged skin demonstrated decreased gene expression of senescence markers p16 and p21, accompanied by reductions in SA-β-gal- and p21-positive cells compared to DMSO controls. However, ABT-263 also triggered a temporary inflammatory response and macrophage infiltration in the skin. Bulk RNA sequencing of ABT-263-treated skin revealed prompt upregulation of genes associated with wound healing pathways, including hemostasis, inflammation, cell proliferation, angiogenesis, collagen synthesis, and extracellular matrix organization. Aged mice skin pre-treated wi
→ call web_fetch({"max_chars":12000,"url":"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&id=PMC11810067&retmode=xml"})
→ call web_fetch({"max_chars":12000,"url":"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&id=PMC11810067&retmode=text"})
【tool:web_fetch】
{"ok": true, "url": "https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&id=PMC11810067&retmode=xml", "status": 200, "content_type": "text/xml; charset=UTF-8", "text": "pmc Aging (Albany NY) 1105 aging Aging Aging (Albany NY) 1945-4589 Impact Journals, LLC PMC11810067 PMC11810067.1 11810067 11810067 39630941 10.18632/aging.206165 206165 206165 1 Research Paper Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing Shvedova Maria 1 * Thanapaul Rex Jeya Rajkumar Samdavid 1 * Ha Joy 1 Dhillon Jannat 1 Shin Grace H. 1 Crouch Jack 1 Gower Adam C. 2 Gritli Sami 1 Roh Daniel S. 1 1 Division of Plastic and Reconstructive Surgery, Department of Surgery, Boston University Aram V. Chobanian and Edward Avedisian School of Medicine, Boston, MA 02108, USA 2 Clinical and Translational Science Institute (CTSI), Boston University Aram V. Chobanian & Edward Avedisian School of Medicine, Boston, MA 02108, USA * Equal contribution Correspondence to: Daniel S. Roh; email: droh@bu.edu 31 1 2025 03 12 2024 17 1 481809 16 32 23 7 2024 11 11 2024 31 01 2025 11 02 2025 13 02 2025 Copyright: © 2024 Shvedova et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Topical ABT-263 treatment reduces aged skin senesce
【tool:web_fetch】
{"ok": true, "url": "https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&id=PMC11810067&retmode=text", "status": 200, "content_type": "text/xml; charset=UTF-8", "text": "pmc Aging (Albany NY) 1105 aging Aging Aging (Albany NY) 1945-4589 Impact Journals, LLC PMC11810067 PMC11810067.1 11810067 11810067 39630941 10.18632/aging.206165 206165 206165 1 Research Paper Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing Shvedova Maria 1 * Thanapaul Rex Jeya Rajkumar Samdavid 1 * Ha Joy 1 Dhillon Jannat 1 Shin Grace H. 1 Crouch Jack 1 Gower Adam C. 2 Gritli Sami 1 Roh Daniel S. 1 1 Division of Plastic and Reconstructive Surgery, Department of Surgery, Boston University Aram V. Chobanian and Edward Avedisian School of Medicine, Boston, MA 02108, USA 2 Clinical and Translational Science Institute (CTSI), Boston University Aram V. Chobanian & Edward Avedisian School of Medicine, Boston, MA 02108, USA * Equal contribution Correspondence to: Daniel S. Roh; email: droh@bu.edu 31 1 2025 03 12 2024 17 1 481809 16 32 23 7 2024 11 11 2024 31 01 2025 11 02 2025 13 02 2025 Copyright: © 2024 Shvedova et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Topical ABT-263 treatment reduces aged skin senesc
→ call run_python({"code":"import requests, re, xml.etree.ElementTree as ET\nurl='https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&id=PMC11810067&retmode=xml'\nxml = requests.get(url, timeout=20).text\nprint('len', len(xml))\nprint(xml[:200])\n# quick search for Figure 6 and headings\nfor pat in ['Figure 6', 'Fig. 6', 'wound closure', 'day 3', 'day 6', 'day 9', 'day 12', 'day 15']:\n print(pat, x)
【tool:run_python】
{"ok": true, "stdout": "", "stderr": "Traceback (most recent call last):\n File \"/root/Sisyphus/workspace/_run_1777144522559.py\", line 1, in <module>\n import requests, re, xml.etree.ElementTree as ET\nModuleNotFoundError: No module named 'requests'\n", "returncode": 1}
→ call run_python({"code":"import urllib.request, re\nurl='https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&id=PMC11810067&retmode=xml'\nxml = urllib.request.urlopen(url, timeout=20).read().decode('utf-8', errors='replace')\nprint('len', len(xml))\nfor pat in ['Figure 6', 'wound closure', 'day 3', 'day 6', 'day 9', 'day 12', 'day 15', 're-epithelial', 'histological']:\n print(pat, xml.find(pat))\)
【tool:run_python】
{"ok": true, "stdout": "atment, we assessed the impact of topical ABT-263 treatment on subsequent wound healing in aged mice. 24-month-old male mice received either 5μM ABT-263 in DMSO or DMSO for 5 days followed by creation of a 1cm full-thickness dorsal skin wound five days after the last day of treatment (<xref rid=\"f6\" ref-type=\"fig\">Figure 6A</xref>). Mice treated with ABT-263 exhibited a significantly accelerated time to achieve complete wound closure, which became statistically significant by day 15 (<xref rid=\"f6\" ref-type=\"fig\">Figure 6B</xref>, <xref rid=\"f6\" ref-type=\"fig\">6C</xref>). 33% of ABT-263-treated mice had completely healed by day 18, in contrast to 0% of DMSO-treated mice (<xref rid=\"f6\" ref-type=\"fig\">Figure 6D</xref>). By day 24, 80% of ABT-263-treated mice had completely healed compared to only 56.3% in the DMSO group, representing a 1.4x fold improvement in complete healing rate.</p><fig position=\"float\" fig-type=\"figure\" id=\"f6\" orienta\n\nPAT Figure 6 idx 24464\naged skin before injury improves subsequent time to wound closure</title><p>Given the substantial upregulation of wound-healing-related genes and pathways following topical ABT-263 treatment, we assessed the impact of topical ABT-263 treatment on subsequent wound healing in aged mice. 24-month-old male mice received either 5μM ABT-263 in DMSO or DMSO for 5 days followed by creation of a 1cm full-thickness dorsal skin wound five days after the last day of treatment (<xr
→ call run_python({"code":"import urllib.request, re\nxml = urllib.request.urlopen('https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&id=PMC11810067&retmode=xml', timeout=20).read().decode('utf-8', errors='replace')\n# extract Figure 2 and Figure 6 captions/contexts\nfor fig in ['f2','f6']:\n idx = xml.find(f'id=\"{fig}\"')\n print('\\n====', fig, 'idx', idx, '====')\n if idx!=-1:\n p)
【tool:run_python】
{"ok": true, "stdout": "reatment (<xref rid=\"f6\" ref-type=\"fig\">Figure 6A</xref>). Mice treated with ABT-263 exhibited a significantly accelerated time to achieve complete wound closure, which became statistically significant by day 15 (<xref rid=\"f6\" ref-type=\"fig\">Figure 6B</xref>, <xref rid=\"f6\" ref-type=\"fig\">6C</xref>). 33% of ABT-263-treated mice had completely healed by day 18, in contrast to 0% of DMSO-treated mice (<xref rid=\"f6\" ref-type=\"fig\">Figure 6D</xref>). By day 24, 80% of ABT-263-treated mice had completely healed compared to only 56.3% in the DMSO group, representing a 1.4x fold improvement in complete healing rate.</p><fig position=\"float\" fig-type=\"figure\" id=\"f6\" orientation=\"portrait\"><label>Figur\n---\n\nPAT day 18\n). Mice treated with ABT-263 exhibited a significantly accelerated time to achieve complete wound closure, which became statistically significant by day 15 (<xref rid=\"f6\" ref-type=\"fig\">Figure 6B</xref>, <xref rid=\"f6\" ref-type=\"fig\">6C</xref>). 33% of ABT-263-treated mice had completely healed by day 18, in contrast to 0% of DMSO-treated mice (<xref rid=\"f6\" ref-type=\"fig\">Figure 6D</xref>). By day 24, 80% of ABT-263-treated mice had completely healed compared to only 56.3% in the DMSO group, representing a 1.4x fold improvement in complete healing rate.</p><fig position=\"float\" fig-type=\"figure\" id=\"f6\" orientation=\"portrait\"><label>Figure 6</label><caption><p><bold>ABT-263 skin pre-treatment a
→ call read_note({"title":"ABT-263 后炎症与修复回落必须靠纵向时间序列判定"})
【tool:read_note】
{"ok": true, "title": "ABT-263 后炎症与修复回落必须靠纵向时间序列判定", "tags": "fact lesson method ABT-263 OSK [[Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing]]", "text": "!! ABT-263 后炎症与修复回落的时间序列只能从纵向读出判定\n当局部 senolytic 研究只给出给药结束、造伤时点和“temporary inflammatory response / macrophage infiltration”这类定性结论时，不能把其中任意一个单点当作“恢复已完成”的证据。[[Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing]] 这类设计最多说明清除和恢复程序在同一窗口内被触发，但并不能反推出炎症或修复已经回落。\n\n!! 为什么单点不足\n# 若只有“5 days after treatment”这样的时间锚点，它只是下一次干预发生的时刻，不是炎症消退时刻。\n# 若摘要只说存在 //temporary inflammatory response//，它只表明炎症是短暂的，不等于已经回到基线。\n# 若 bulk RNA-seq 看到 wound-healing pathways 上调，也只能说明修复程序被激活，不能证明它随后在何时回落。\n\n!! 可迁移结论\n对任何 [[ABT-263]] → [[OSK]] 顺序设计，恢复窗必须由纵向时间序列来估计，而不是由单个终点或单个时间锚点外推。实际规则应是：''清除锚'' 与 ''恢复锚'' 必须分开证明；前者可由 washout / half-life / 给药结束给出保守下界，后者必须由炎症、免疫浸润、修复转录或组织学的回落曲线给出。\n\n!! 当前证据状态\n截至目前，公开可检材料仍不足以从这篇 ABT-263 皮肤研究中核出一个可复现的炎症/修复回落完成时间点；因此本轮只能把“需要时间序列”这一方法结论沉淀下来，不能把具体回落天数当成事实写死。"}
→ call write_note({"tags":["fact","method","lesson","ABT-263","OSK","[[Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing]]"],"text":"!! ABT-263 后炎症与修复回落的时间序列只能从纵向读出判定\n当局部 senolytic 研究只给出给药结束、造伤时点和“temporary inflammatory response / macrophage infiltration”这类定性结论时，不能把其中任意一个单点当作“恢复已完成”的证据。[[Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound )
【tool:write_note】
{"ok": true, "path": "/root/Sisyphus/wiki/tiddlers/ABT-263_后炎症与修复回落必须靠纵向时间序列判定.tid", "title": "ABT-263 后炎症与修复回落必须靠纵向时间序列判定"}
→ call task_done({"id":"n193","result":"从 PMC XML/全文结构化回退核出 Figure 2 为 5 天游程后的终点炎症读出（总细胞/HPF、F4/80+ macrophage/HPF），Figure 6 为停药后 5 天游程再造伤并纵向追踪 wound contraction / complete healing（day 15 显著、day 18 33% vs 0%、day 24 80% vs 56.3%）；确认没有停药前恢复回落曲线，不能据此把回落完成时间写死。"})
【tool:task_done】
{"ok": true, "id": "n193", "status": "done", "next_focus": "root"}
【assistant】
已完成本轮抽取。
关键信息：
- Figure 2：是**连续 5 天游程后**的终点读出，指标为**总细胞浸润/HPF**与 **F4/80+ macrophage/HPF**，只能证明急性炎症被触发，不能证明回落完成。
- Figure 6：实验顺序是**5 天 topical ABT-263**，然后在**最后一次给药后 5 天**造伤；纵向读出是 **wound contraction / complete healing**，其中 **day 15** 开始显著，**day 18** 为 **33% vs 0%**，**day 24** 为 **80% vs 56.3%**。
- 结论：这篇文章支持“预处理加速后续愈合”，但**不支持**“停药前炎症/修复已回落到基线”，所以 recovery anchor 仍不能写死。
我已把可复用结论沉淀到记忆中。
<NEXT_FOCUS>root：继续把 ABT-263 → OSK 的保守最小间隔从“纸面下界”推进到“按图表可引用的恢复锚”，优先找停药后到造伤前是否存在任何纵向炎症/组织学回落数据</NEXT_FOCUS>
========== REFLECTION ==========
{
"progress": "从 PMC11810067 的 XML 里核出了 ABT-263 局部处理后的关键纵向时间点：停药后 5 天再造伤，闭合差异到 day 15 才显著，day 18/24 的完全愈合率也已可量化。",
"failure": "HTML 页面被 reCAPTCHA 拦截后，虽然成功回退到 PubMed/PMC XML，但本轮没有提炼出任何超出既有“纵向时间序列判定”框架的新、普适经验。",
"empirical_actions": "调用了 search_memory、web_fetch PMC 页面、web_search、PubMed efetch XML、PMC efetch XML，以及 run_python 解析 XML；获取到的外部新数据是 ABT-263 研究中“停药后 5 天造伤、day 15 显著、day 18 为 33% 完全愈合、day 24 为 80% vs 56.3%”这些时间序列结果。",
"lesson": {
"worthy": false,
"title": "",
"extends_existing": "",
"tags": [],
"text": ""
},
"next_focus": "只盯一个子问题：把这篇 ABT-263 论文里“停药后多久再造伤”和“哪些读出在什么天数才真正回落”拆成可复用的 schedule anchor / recovery anchor 判定规则。"
}